A Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir in Combination With Rifampin in HIV-1-infected Patients With Tuberculosis
Phase of Trial: Phase IV
Latest Information Update: 10 Dec 2016
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Rifampicin (Primary) ; Ritonavir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 09 Jun 2016 Planned End Date changed from 1 Mar 2017 to 1 Mar 2018.
- 09 Jun 2016 Planned primary completion date changed from 1 Feb 2017 to 1 Dec 2017.
- 09 Jun 2016 Status changed from not yet recruiting to recruiting.